MindMaze Therapeutics Holding SA
Research MindMaze Therapeutics Holding SA (MMTX.SW) with Bullrun company financials, valuation charts, model signals, and historical stock context.
Key Metrics
- TickerMMTX.SW
- ExchangeSW
- CountrySwitzerland
- SectorHealthcare
- IndustryBiotechnology
- CurrencyCHF
- Financial periodFY2025
- RevenueCHF 642.00K
- Revenue growth-92.4%
- Net income-CHF 9.91M
- Free cash flow-CHF 7.23M
- Gross margin92.1%
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CHF 642.00K | -CHF 9.91M | -CHF 7.23M | 92.1% | -0.48 | CHF 9.47M | CHF 1.81M | CHF 38.34M |
| FY2024 | CHF 8.42M | -CHF 17.12M | -CHF 3.09M | 69.4% | -1.37 | CHF 15.08M | CHF 2.14M | CHF 36.66M |
| FY2023 | CHF 6.03M | -CHF 98.18M | -CHF 18.06M | 71.2% | -8.35 | CHF 14.56M | CHF 2.96M | CHF 52.23M |
| FY2022 | CHF 6.08M | -CHF 50.79M | -CHF 24.65M | 79.4% | -4.81 | CHF 19.24M | CHF 3.06M | CHF 145.42M |
| FY2021 | CHF 3.32M | -CHF 34.71M | -CHF 49.43M | -495.4% | -4 | CHF 44.76M | CHF 3.01M | CHF 181.53M |
About MindMaze Therapeutics Holding SA
MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally. The company offers MindPod system, a supervised in-clinic neurorehabilitation system designed to initiate and intensify the recovery journey; MindMotion GO, which extends protocolized neurotherapeutics into outpatient and home settings;
Related stock research
Other Healthcare stocks
Frequently asked questions
What does MindMaze Therapeutics Holding SA do?
MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally.